Pioglitazone (Vexazone) 30 mg tab: Supply issue

Supply issue Active

Due to an increase in demand, stock of pioglitazone (Vexazone) tablets 30 mg is limited (Pharmacode: 2479443)

2 April 2024 | Alternative added

We have received clinical advice that 2 x 15 mg tablets is a suitable alternative to the 30 mg tablet. 

Resupply is now anticipated in late April 2025. 

Affected product

Viatris, the supplier, advises that there is very limited stock of pioglitazone (Vexazone) tab 30 mg in the supply chain due to increase demand.

  • Chemical: Pioglitazone
  • Presentation: Tab 30 mg
  • Brand: Vexazone
  • Pharmacode: 2479443

Schedule listing for pioglitazone(external link)

The other strengths of pioglitazone remain available.

Alternative: 2 x 15 mg tablets

We have received clinical advice that 2 x 15 mg tablets is a suitable alternative to the 30 mg tablet.

Expected resupply

We are not expecting pharmacies to experience difficulties with supply because wholesalers received stock this week. It is possible to use two 15 mg tablets to make up the dose if pharmacies experience difficulties (Rule 3.4.2 applies).

Viatris expects to have stock available again by late April 2025. Although it may take another one to two weeks for stock to reach pharmacies around the motu.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, Pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)